(b)(4) initial mdr.A follow up will be submitted if additional information becomes available.(b)(4).Bd was unable to perform a thorough investigation as no sample, lot, or batch number were provided.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.
|
Material no.Unknown, batch no.Unknown.It was reported that the path of the vein became red after the use of chloraprep and inserting a catheter.Verbatim: the health manager was contacted by a colleague because in her department 2 nurses communicated to her problems with lymphangitis following the use of chloraprep®.After disinfecting the skin using chloraprep® and after inserting the catheter, they noticed that the ¿path¿ of the vein was red.And that the next day the patient presented with lymphangitis but without pain and because of this they were going to re-perfused the patient.Per vendor follow-up: several patients, between 2 and 3 but not identified.The nurse doesn¿t remember exactly 1ml applicator was used each time.Red vein path has appeared after just after catheter insertion local atb sometimes administered.No known concomitant medical history.Sometimes,catheter was removed and patient were re-catheterized, only if pain was associated and/or if lymphangitis or red vein path lasted more than 24h.No specific medicine was used to resolve the side effect.
|